» Authors » P Hopwood

P Hopwood

Explore the profile of P Hopwood including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 81
Citations 2786
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hopwood P, MacEachen E, Crouch M, Neiterman E, McKnight E, Malachowski C
J Occup Rehabil . 2024 Jan; 34(4):783-792. PMID: 38265610
Purpose: This paper describes how Canadian Return to Work coordinators (RTWC) framed their job roles relative to workers in ways that went beyond the usual professional norms of helping worker...
2.
Mills J, Haviland J, Moynihan C, Bliss J, Hopwood P
Clin Oncol (R Coll Radiol) . 2018 Apr; 30(7):433-441. PMID: 29653749
Aims: Exploratory analysis of patients' unsolicited written comments in the first 2 years of the Standardisation of Breast Radiotherapy (START) trial quality of life study highlighted a potential effect of...
3.
4.
Haviland J, Hopwood P, Mills J, Sydenham M, Bliss J, Yarnold J
Clin Oncol (R Coll Radiol) . 2016 Feb; 28(6):345-353. PMID: 26868286
Aims: In radiotherapy trials, normal tissue effects (NTE) are important end points and it is pertinent to ask whether patient-reported outcome measures (PROMs) could replace clinical and/or photographic assessments. Data...
5.
Winters Z, Emson M, Griffin C, Mills J, Hopwood P, Bidad N, et al.
Br J Surg . 2014 Dec; 102(1):45-56. PMID: 25451179
Background: Breast reconstruction aims to improve health-related quality of life after mastectomy. However, evidence guiding patients and surgeons in shared decision-making concerning the optimal type or timing of surgery is...
6.
Hall E, Cameron D, Waters R, Barrett-Lee P, Ellis P, Russell S, et al.
Eur J Cancer . 2014 Jul; 50(14):2375-89. PMID: 25065293
Background: The TACT trial (CRUK/01/001) compared adjuvant sequential FEC-docetaxel (FEC-D) chemotherapy with standard anthracycline-based chemotherapy of similar duration in women with early breast cancer. Results at a median of 5...
7.
Leibovitch I, Gillatt D, Hopwood P, Iversen P, Mansel R, McLeod D, et al.
Clin Drug Investig . 2013 Jan; 23(3):205-15. PMID: 23340926
Objective: To present management options for gynaecomastia and mastodynia associated with nonsteroidal antiandrogen therapy, supported by relevant data and case studies. Background: Gynaecomastia (male breast enlargement) and breast pain/ sensitivity...
8.
Campbell H, Epstein D, Bloomfield D, Griffin S, Manca A, Yarnold J, et al.
Eur J Cancer . 2011 Jul; 47(17):2517-30. PMID: 21741831
Background: The risk of recurrence following surgery in women with early breast cancer varies, depending upon prognostic factors. Adjuvant chemotherapy reduces this risk; however, increasingly effective regimens are associated with...
9.
Challberg J, Ashcroft L, Lalloo F, Eckersley B, Clayton R, Hopwood P, et al.
Br J Cancer . 2011 Jun; 105(1):22-7. PMID: 21654687
Background: Women at high ovarian cancer risk, especially those with mutations in BRCA1/BRCA2, are encouraged to undergo bilateral risk-reducing salpingo-oophorectomy (BRRSPO) prior to the natural menopause. The decision to use...
10.
Howell S, Searle C, Goode V, Gardener T, Linton K, Cowan R, et al.
Br J Cancer . 2009 Aug; 101(4):582-8. PMID: 19672261
Background: Supradiaphragmatic radiotherapy (SRT) to treat Hodgkin's lymphoma (HL) at a young age increases the risk of breast cancer (BC). A national notification risk assessment and screening programme (NRASP) for...